Automating MS-Based biotherapeutic characterization workflows for developability assessment

Automating MS-Based biotherapeutic characterization workflows for developability assessment

Tuesday, November 3, 2020 10:20 AM to 10:40 AM · 20 min. (Africa/Abidjan)

European Antibody Congress

CMC & developability

Presentation

Information

Christian Hug, Senior Scientist, NIBR Biologics Center - Characterization, Formulation & Bioinformatics, Novartis

Genedata AGWith award-winning platforms and deep domain expertise, Genedata solutions boost the efficiency, throughput, and quality of large-molecule R&D. Genedata platforms support the entire biologics workflow, from screening, protein engineering and optimization, expression, purification, MS characterization, analytics and QC, and developability assessment to upstream and downstream process development and drug formulation.

Log in

See all the content and easy-to-use features by logging in